Merck & Co., Inc. — Patent Applications
Published USPTO patent applications filed under applicant “Merck & Co., Inc. / MERCK & CO., INC.” — pending requests, not granted patents. Where a filing continues an already-granted parent, the parent’s number is shown.
Newest filing on this page: 2022-09-06. Last loaded from the USPTO Open Data Portal on 2026-06-11. This list is not refreshed on a schedule and was last loaded 135 days ago, so newer applications may be missing. USPTO publishes most applications about 18 months after they are filed.
Applications on file
Every row is a patent application — a pending request, not a granted patent. “Granted Parent” shows the parent patent number when a filing continues an already-granted family. Newest filing date first. Source: USPTO Open Data Portal (public).
| Title | Filed | Application # | Status | Granted Parent |
|---|---|---|---|---|
| METHODS FOR EMPLOYING MASS SPECTROMETRY TECHNIQUES TO SEQUENCE AND ANALYZE BIOLOGICAL MOLECULES | 2022-09-06 | 63403984 | Provisional Application Expired | — |
| MULTIPLEXED INDUCTIVE IONIZATION SYSTEMS AND METHODS | 2019-05-31 | 62855090 | Provisional Application Expired | — |
| ASSAYS FOR RESISTANCE TO ECHINOCANDIN-CLASS DRUGS | 2017-05-22 | 15601450 | Patented Case | parent 9657334 |
| COMPOUNDS, COMPOSITIONS AND METHODS | 2014-12-23 | 62096077 | Provisional Application Expired | — |
| ASSAYS FOR RESISTANCE TO ECHINOCANDIN-CLASS DRUGS | 2014-06-16 | 14305499 | Patented Case | parent 8753819 |
| LIVE, ATTENTUATED RESPIRATORY SYNCYTIAL VIRUS | 2009-11-03 | PCTUS2009063024 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| 2,3-DISUBSTITUTED PIPERIDINE OREXIN RECEPTOR ANTAGONISTS | 2009-10-15 | PCTUS2009060759 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| 3H-IMIDAZO[4,5-B]PYRIDIN-5-OL DERIVATIVES USEFUL IN THE TREATMENT OF GPR81 RECEPTOR DISORDERS | 2009-09-10 | PCTUS2009005083 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| NOVEL SUBSTITUTED AZABENZOXAZOLES | 2009-05-28 | PCTUS2009045376 | PCT - IPER (International Preliminary Examination Report) 409-416 Mailed | — |
| OXAZOLOBENZIMIDAZOLE DERIVATIVES | 2009-05-08 | PCTUS2009043299 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| METHODS OF USING MIR210 AS A BIOMARKER FOR HYPOXIA AND AS A THERAPEUTIC AGENT FOR TREATING CANCER | 2009-04-16 | PCTUS2009040788 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| PANCREATIC BETA-CELL MASS BIOMARKER | 2009-04-10 | PCTUS2009040156 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| INTEGRIN TARGETING AGENTS AND METHODS OF USING SAME | 2009-03-13 | PCTUS2009037114 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| AHCY HYDROLASE INHIBITORS FOR TREATMENT OF HYPER HOMOCYSTEINEMIA | 2009-02-18 | PCTUS2009034344 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| TETRAHYDROTHIENO PYRIDINES | 2009-02-11 | PCTUS2009033718 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| PRODRUGS OF CGRP RECEPTOR ANTAGONIST | 2009-02-04 | PCTUS2009033008 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| P2X3 RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN | 2008-10-29 | PCTUS2008012271 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN | 2008-10-29 | PCTUS2008012270 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| QUINOLIZIDINONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS | 2008-10-15 | PCTUS2008011752 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| PEPTIDE COMPOUNDS FOR TREATING OBESITY AND INSULIN RESISTANCE | 2008-10-14 | PCTUS2008011733 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| MICRODRIVE AND MODULAR MICRODRIVE ASSEMBLY FOR POSITIONING INSTRUMENTS IN ANIMAL BODIES | 2008-09-03 | PCTUS2008075111 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| ANTIDIABETIC AZAINDOLES AND DIAZAINDOLES | 2008-06-25 | PCTUS2008007919 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| TRICYCLIC ANILIDE HETEROCYCLIC CGRP RECEPTOR ANTAGONISTS | 2008-06-03 | PCTUS2008006964 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| CARBOXAMIDE HETEROCYCLIC CGRP RECEPTOR ANTAGONISTS | 2008-06-02 | PCTUS2008006958 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| ANTIGEN-BINDING PROTEINS TARGETING S. AUREUS ORF0657N | 2008-05-29 | PCTUS2008006791 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| PYRIDYL PIPERIDINE OREXIN RECEPTOR ANTAGONISTS | 2008-05-22 | PCTUS2008006563 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| CYCLOPROPYL PYRROLIDINE OREXIN RECEPTOR ANTAGONISTS | 2008-05-19 | PCTUS2008006396 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| OXO BRIDGED DIAZEPAN OREXIN RECEPTOR ANTAGONISTS | 2008-05-14 | PCTUS2008006128 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| SPIROINDALONES | 2008-05-12 | PCTUS2008063365 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| METHOD OF TREATMENT USING FUSED AROMATIC COMPOUNDS HAVING ANTI-DIABETIC ACTIVITY | 2008-05-02 | PCTUS2008005726 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| 2-SUBSTITUTED INDOLE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS | 2008-04-22 | PCTUS2008005156 | PCT - IPER (International Preliminary Examination Report) 409-416 Mailed | — |
| TRIAZOLE DERIVATIVES WHICH ARE SMO ANTAGONISTS | 2008-04-15 | PCTUS2008004862 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| NOVEL 1,8-NAPHTHYRIDINE COMPOUNDS | 2008-04-14 | PCTUS2008004817 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| ARYL HETEROCYCLIC CGRP RECEPTOR ANTAGONISTS | 2008-04-11 | PCTUS2008004786 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| BICYCLIC ANILIDE HETEROCYCLIC CGRP RECEPTOR ANTAGONISTS | 2008-04-11 | PCTUS2008004694 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| CGRP RECEPTOR ANTAGONISTS WITH TERTIARY AMIDE, SULFONAMIDE, CARBAMATE AND UREA END GROUPS | 2008-04-07 | PCTUS2008004528 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| SUBSTITUTED FURO[2,3-B] PYRIDINE DERIVATIVES AS CANNABINOID-1 RECEPTOR MODULATORS | 2008-04-07 | PCTUS2008004533 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| ISOLATED NUCLEIC ACID MOLECULES CORRESPONDING TO MICRO RNA 145 (MIRNA-145) AND THEIR USE IN TREATING COLON CANCER | 2008-04-07 | PCTUS2008004536 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| THERAPEUTIC AGENTS | 2008-04-03 | PCTUS2008004336 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| ANTI-HYPERCHOLESTEROLEMIC COMPOUND | 2008-03-28 | PCTUS2008004140 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| BROADLY REPRESENTATIVE ANTIGEN SEQUENCES AND METHOD FOR SELECTION | 2008-03-26 | PCTUS2008003947 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| COMBINATION THERAPY FOR THE TREATMENT-OF LOWER URINARY TRACT SYMPTOMS | 2008-03-25 | PCTUS2008003873 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| SUBSTITUTED PYRIDO[3,2-E][1,2,4]TRIAZOLO[4,3-C]PYRIMIDINE DERIVATIVES AS CANNABINOID-1 RECEPTOR MODULATORS | 2008-03-24 | PCTUS2008003847 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| SUBSTITUTED PYRIDO [2, 3-D] PYRIMIDINE DERIVATIVES AS CANNABINOID-1 RECEPTOR MODULATORS | 2008-03-24 | PCTUS2008003848 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| METHOD FOR DETECTING AUTOPROCESSED, SECRETED PCSK9 | 2008-03-21 | PCTUS2008003800 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| MINERALOCORTICOID RECEPTOR MODULATORS | 2008-03-19 | PCTUS2008003600 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| POLYPEPTIDES FOR INDUCING A PROTECTIVE IMMUNE RESPONSE AGAINST STAPHYLOCOCCUS EPIDERMIDIS | 2008-03-14 | PCTUS2008003389 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| METHODS FOR MONITORING GAMMA SECRETASE INHIBITION IN VIVO | 2008-03-11 | PCTUS2008003238 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| INHIBITORS OF JANUS KINASES AND/OR 3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE-1 | 2008-03-10 | PCTUS2008003206 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| MONOCYCLIC ANILIDE SPIROLACTAM CGRP RECEPTOR ANTAGONISTS | 2008-03-07 | PCTUS2008003078 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
How to read this
Every row here is an application — a request the USPTO has not yet decided. In plain English: these filings show where Merck & Co., Inc.’s R&D effort is pointed right now, often 18–24 months before any product ships — but an application can be amended, abandoned, or rejected, and most confer no enforceable rights until granted. A “granted parent” tag means the filing continues a patent family that already has a grant — the new claims themselves are still pending. Filings are matched by applicant name, so work filed under subsidiary or research-entity names may not appear. Source: USPTO Open Data Portal (public).
How many Merck & Co., Inc. patent applications does this page show?
This page lists 50 U.S. patent applications Oxford Ledge has matched to Merck & Co., Inc, of which 2 continue an already-granted patent family. It is not a count of everything the company has on file. Every row is an application (a pending request to the USPTO), not a granted patent.
What is the difference between a patent application and a granted patent?
A patent application is a pending request filed with the USPTO; a granted patent is one the USPTO has examined and issued. These pages track applications, which signal a company's R&D direction before any patent is granted.
Where does this patent data come from?
The USPTO Open Data Portal (public), matched to the company's applicant registrations.